leisure time -WSS

leisure time

author：knowledge 2025-10-02 17:21:15 - browse：14222

prostate cancer cells — Prostate cancer cells seen under the microscope. NIH

Prostate cancer tends to be the tortoise of tumors, growing and spreading slowly. When cancerous cells escape the golf ball-sized prostate, they can lodge in various places throughout the body. New research shows that where these cells go can affect how long a man survives.

When prostate cancer spreads, or metastasizes, about three-quarters of the time it takes up residence in the bones. Less common locations are the lungs, liver, and lymph nodes.

An international team of researchers pooled information from nine clinical trials to estimate the average survival times for men with prostate cancer that had spread to four different tissues. Metastasis to the lymph nodes was linked to the longest survival; metastasis to the liver led to the shortest.

“This important study confirms that one size does not fit all when it comes to metastatic prostate cancer,” said Dr. Marc Garnick, a prostate cancer specialist at Beth Israel Deaconess Medical Center in Boston.

The new study, led by Susan Halabi, a professor of biostatistics at Duke University School of Medicine, suggests that prostate cancer that skips the bones and spreads to the liver and lungs may represent a different disease than prostate cancer that invades bones or lymph nodes. The results were published Monday in the Journal of Clinical Oncology.

Median survival for metastatic prostate cancer is affected by metastasis site. Mark Dubowski for Duke Health

“A better understanding of how metastatic prostate cancer behaves in different locations is letting us tailor diagnostic approaches and treatments that we hope will improve outcomes,” Garnick said.

Previous article： Walensky prepares to leave CDC — and Congress — behind
Next article： App could help diagnose ear infections more accurately — and at home

WSS

Health AI adoption puts security, privacy startups on investors' radar

Anthos stroke drug appears safer than common blood thinner

Hospitals look to new technology to keep health care workers safe

Asbestos, a deadly carcinogen, banned by EPA

UnitedHealth increases loan offers after Change Healthcare outage

Readout Newsletter: The latest at Gilead, Catalent, and the NIH

focus

leisure time

hotspot

Anesthesiologist group: stop taking Ozempic before surgery

Why medical students are struggling with mental health

Jerome Adams on the need for new antivirals for Covid

Weight loss drug Wegovy cuts risk of heart attacks in milestone trial

Medicare details structure of new drug price negotiation program

A daunting task: navigating dual Medicare, Medicaid eligibility

Trump demands the U.S. pay no more for drugs than other countries … again

Weight loss drug Wegovy cuts risk of heart attacks in milestone trial

Moonlake's readout produced a cash windfall. Risks remain

Does good food count as health care? Study aims to find out

hotspot

Readout Newsletter: What is Casgevy? Does Wegovy hurt muscle?

Does good food count as health care? Study aims to find out

U.K. not yet recommending Vertex's CRISPR therapy for sickle cell

Nurses recount patients attacks

Congress must reauthorize a committee to support older Americans

UnitedHealth increases loan offers after Change Healthcare outage

hotspot

knowledge

focus

explore